Antiparkinsonian drugs contraindicated with Dolmatil
The summary of product characteristics for Dolmatil (sulpiride; Sanofi) now states that use of antiparkinsonian drugs (including ropinirole) with sulpiride is contraindicated. Additionally, in patients on both sulpiride and lithium, both should be discontinued at first signs of neurotoxicity.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068956
Recommended from Pharmaceutical Press